Audited Results of Aarti Pharmalabs Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	1,797.55	1,771.35	1,502.13	1,511.25	941.02
Manufacturing Expenses	0	80.19	82.92	282.54	167.97
Personnel Expenses	170.48	152.88	130.33	122.16	79.98
Selling Expenses	0	2.64	6.40	5.13	0.31
Administrative Expenses	433.02	229.84	184.35	33.92	21.16
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,424.64	1,344.81	1,155.97	1,202.91	761.24
Operating Profit	372.91	426.54	346.16	308.34	179.79
Other Recurring Income	15.32	14.49	11.01	1.28	2.51
Adjusted PBDIT	388.23	441.03	357.17	309.62	182.30
Financial Expenses	46.90	25.63	16.63	20.49	11.34
Depreciation	104.30	79.06	66.01	55.77	37.23
Other Write offs	0	0	0	0	0
Adjusted PBT	237.03	336.34	274.52	233.36	133.73
Tax Charges	58.04	78.99	73.87	61.63	27
Adjusted PAT	179	257.35	200.65	171.73	106.73
Non Recurring Items	-2.79	-1.42	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	176.20	257.35	200.65	171.73	106.73
Equity Dividend	0	31.72	18.13	18.13	0
Preference Dividend	0	0	0	0	0
Retained Earnings	176.20	1,266.28	1,042.07	859.55	705.95

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article